# Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome

> **NCT00003790** · — · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 496 (actual)

## Conditions studied

- Leukemia
- Myelodysplastic Syndromes

## Interventions

- **GENETIC:** polymerase chain reaction
- **OTHER:** flow cytometry

## Key facts

- **NCT ID:** NCT00003790
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1995-02
- **Primary completion:** 2002-04
- **Final completion:** 2006-09
- **Target enrollment:** 496 (ACTUAL)
- **Last updated:** 2014-08-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003790, "Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00003790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*